Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 925.00 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 924.50 | 925.00 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 925.00 | GBX |
Clinigen (CLIN) Share Charts1 Year Clinigen Chart |
|
1 Month Clinigen Chart |
Intraday Clinigen Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/4/2022 | 15:19 | Clinigen - solid looking growth stock | 334 |
| 24/2/2021 | 22:59 | Clinigen - Speciality Pharmaceuticals | 1,052 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 17/1/2022 09:25 by kenmitch The lower share price well below that 925p higher offer, reflects the risk of the bid failing. IF it does the share pice could well fall quite heavily, giving a great chance for those of us who sold recently a chance to buy again.There’s also the chance of a new bidder and a bidding war......but bearing in mind the share price drifting lower last week and down again today, suggests the market (which is often a good guide in bid situations) thinks this is unlikely. So investors deciding to continue to hold could do very well.....but also risk significant share price fall. Those who’ve sold have surely done very well and have banked those gains. |
Posted at 17/1/2022 08:32 by ali47fish amazed that nobody is commenting on bidco raising the offer for clin |
Posted at 09/12/2021 09:12 by tomps2 Andy Brough interview with PIWORLDAndy Brough mentions Clinigen #CLIN in the latest PIWORLD interview at 17m18s then again at 19m Watch the video here: Or listen to the Podcast here: |
Posted at 08/12/2021 10:33 by hjs KenI agree with what you are saying but I would also add that the "bidder" normally starts with a lower bid. They have the fair value in their DD and based on that figure, they have the flexibility of offering more if needed or there is a rival bid. IMO, based on the reaction of the share price, market thinks there is a rival bidder or the bid will be raised. I do not think one should rush and sell at this price. We have to wait and see what happens in the next few weeks. |
Posted at 08/12/2021 09:25 by kenmitch When the share price goes usefully higher than the price of the agreed bid, it means the market thinks there may be one or maybe more rival bids. Bidding wars are great fun for investors holding that share. Sometimes there is a rival higher bid and sometimes there isn’t but, as has happened with the CLINIGEN share price in recent days, sometimes the market does know what is going on behind the scenes, presumably from chat etc with one or more of those in the know.There’s probably no rush to sell yet. There is now a floor under the share price, unless the bidder walks away which right now seems unlikely. If the share price drops to just below the price of the now agreed bid, that strongly hints that there are unlikely to be any rival bids. |
Posted at 08/12/2021 08:53 by hjs Share price is higher than the offer price because Inst. shareholders know that this company has been sold off cheaply than its fair value. They will not give in and accept the offer price. |
Posted at 08/12/2021 08:46 by r2oo Just sold my stake at a 27 percent profit so happy with that.This but out looks like a done deal and yet the share price is currently at a premium to what share holders will receive if they hold out until the deal is done. |
Posted at 01/12/2021 13:08 by b1nky Anyone know/understand what's going on with share price? |
Posted at 24/11/2021 18:33 by value viper No trading update but clear dissent with institutional investors re pay and director roles - not surprising frankly. The share price performance is dire for what they get paid etc - all aligned with Elliott's now involvement - change is needed |
Posted at 16/9/2021 20:50 by whatja Well that is a second warning, although interspersed with some hope.The product division appears to be the problem….big bet placed on proleukin is not coming good.it May recover but the longer the disruption continues, the greater the chances that a better product takes market share. The share price will recover when the health sector normalises or the company limps along for a couple of years and is sufficiently strong to take a write down…it can then get out from that shadow. The number of wins for services such as cliniport show the potential for a better cleaner business….but what is it worth on a sum of the parts basis broken up? Beware a cheap MBO backed by PE of the good division leaving the rump as a zombie. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
